Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?

Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

SC451 for type 1 diabetes drives upside, but valuation & dilution risk loom. Click here to read more about the SANA stock.

Zhengye Biotechnology Holding Limited ZYBT shares plunged on Wednesday as traders reassessed the stock after an extreme, ...

Biotechnology investors remain confident in the sector's outlook even after a major comeback this year — and they're picking ...

Sana Biotechnology's lead asset still remains to be SC291, repurposed for severe autoimmune disorders instead of blood ...

See the U.S. News rankings for Biotechnology and Applied Microbiology among the top universities in United States. Compare the academic programs at the world's best universities.

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

Key Investor Takeaways ・Zhengye Biotechnology (NASDAQ:ZYBT) said it is not aware of any material non-public information ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Brent Sabatini, Senior Vice President and Chief Accounting Officer, has been appointed Interim Principal Financial Officer, effective July 23 ...